🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Presented at #ASCO24: Among patients who received two 3-week cycles of neoadjuvant ipilimumab and nivolumab, the 12-month event-free survival was 83.7%, as compared with 57.2% among those who received only adjuvant therapy. Full NADINA trial results: nej.md/3wSo3uk

A landmark international clinical trial involving Peter Mac has shown that combination immunotherapy before surgery dramatically improves outcomes in advanced #melanoma and will likely change practise. See the incredible results: petermac.org/about-us/news-…

Amazing work from our v talented fellow ⁦Eyal Mor collaborating with the team ⁦Sheba Medical Center⁩ on this fantastic study ⁦Peter Mac Cancer Centre⁩ 3D-SARC: A Pilot Study Testing the Use of a 3D Augmented-Reality Model in Retroperitoneal Sarcoma link.springer.com/article/10.124…

Our author reflections on the use of augmented reality in retroperitoneal sarcomas. David Gyorki Hayden Snow Annals of Surgical Oncology Sheba Medical Center Peter Mac Cancer Centre link.springer.com/article/10.124…

Top 100 Xfluencers in Sarcoma: Key Opinion Leaders to follow on X (Twitter) in 2024 - OncoDaily oncodaily.com/insight/117698…

Excited to share our latest paper on radiation induced angiosarcoma of the breast ! David Gyorki Hayden Snow

#AMC2024 provides a rare opportunity to hear from expert speakers covering all aspects of #melanoma. Here are just 4 of the speakers & their topics. See all speakers> bit.ly/4e3GNY0 #TogetherAmplifyingImpact #MariaGonzalez David Gyorki Anne Cust Lorey Smith Peter Mac Cancer Centre

Alexandra Gangi, MD sylvie bonvalot European Society of Surgical Oncology (ESSO) Society of Surgical Oncology TARPSWG Alessandro Gronchi Marco Fiore, MD, FACS, FEBSh Chandrajit Raut Gabrielle van Ramshorst, MD FECSM FEBS FSSO sylvie bonvalot is a surgical giant of our time. A true trailblazer. Congrats Sylvie on this achievement. #sarcoma CTOS

Sarah Cheung opens ANZSA's inaugural Community Connect to kick off Day 2 of our #ANZSAASM2024 in Brisbane. We will hear survivor stories, patient experience & share a meditation & reflection workshop with our incredible #sarcoma community. Angela Hong Marianne Phillips

A busy afternoon at ANZSA’s ASM 2024 #ANZSAASM2024 with breakthrough presentations from our international guest Nathalie Gaspar, newly appointed ANZSA Board Director Joanna Connor, the afternoon's host David Gyorki and another stellar presentation from Angela Hong

Kicking off #CTOS2024 with TARPSWG this morning. Marco Fiore, MD, FACS, FEBSh leading the discussion on 🌎 collaboration to standardize RPS terminology 👏👏 #CTOSTweeTOS

@tarpswg semiannual meeting at CTOS annual meeting in San Diego! A full house and a packed agenda to stimulate advances in #retroperitoneal #sarcoma management and research. Entertaining, interactive, and as productive as always if not more! Society of Surgical Oncology European Society of Surgical Oncology (ESSO)

2/4 the implication of histologic organ infiltration for surgical strategy and risk of recurrence, the natural history of PEComa, the outcome over time of a very large series of RPS patients treated at a single Institution with implications for the management of the RPS types

3/4 the accuracy of preop biopsy in RPS to optimize preoperative strategy. Great job everyone! 4 of 6 presentations were from TARPSWG A second era of papers from a large multi-institutional prospective observational study has just started.

Thanks Alessandro Gronchi and TARPSWG ! #RESAR database is an unprecedented occasion to foster insights on #retroperitoneal sarcoma... New research projects are underway on prospective data from 2700+ RPS David Gyorki

#CTOS2024 coming to an end 😅 with Stefano Radaelli Rosalba Miceli Daniela Salvatore farewell seafood lunch after caching up again with #travellingsurgeon Catherine Sarre 🌍🌎🌏 UofT Surgical Oncology Peter Mac Cancer Centre Istituto Tumori Grupo Mexicano de Sarcomas

🏅Estándares de tratamiento en #sarcoma retroperitoneal: 🔸Biopsia preoperatoria 🔬 🔸Referencia a centros de excelencia 🏥 🔸Discusión multidisciplinaria 🖥️ 🔸 Tratamiento individualizado a subtipo histológico 👤 No se pierdan la serie 2 de #webinars de Grupo Mexicano de Sarcomas

Angela Hong, Co-Chair of ANZSA's SAC, co-authored a #groundbreaking study published in The Lancet. The research explores combining pembrolizumab, surgery, and radiotherapy for Stage III soft tissue #sarcoma, potentially revolutionising treatment! thelancet.com/journals/lance…

A proud moment for Omico Australia - Prof David Thomas, receiving NSW’s highest cancer accolade @ the Premier’s Awards, recognising his remarkable work in sarcoma research, genomics & precision oncology. Our sincere thanks for all you do for those living with sarcoma.

Provision of retroperitoneal sarcoma services in England: The case for... sciencedirect.com/science/articl… Thanks to European Journal of Surgical Oncology for publishing our editorial. Looking forward to some healthy debate! Marco Fiore, MD, FACS, FEBSh sylvie bonvalot Alessandro Gronchi David Gyorki Samuel J Ford Fabio Tirotta